- Home
- LDI vs AMLX Comparison
LDI vs AMLX Comparison
Compare LDI & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDI
- AMLX
- Stock Information
- Founded
- LDI 2010
- AMLX 2014
- Country
- LDI United States
- AMLX United States
- Employees
- LDI N/A
- AMLX N/A
- Industry
- LDI Finance: Consumer Services
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- LDI Finance
- AMLX Health Care
- Exchange
- LDI Nasdaq
- AMLX Nasdaq
- Market Cap
- LDI 402.7M
- AMLX 481.9M
- IPO Year
- LDI 2021
- AMLX 2022
- Fundamental
- Price
- LDI $2.34
- AMLX $5.19
- Analyst Decision
- LDI Sell
- AMLX Buy
- Analyst Count
- LDI 3
- AMLX 7
- Target Price
- LDI $2.60
- AMLX $7.60
- AVG Volume (30 Days)
- LDI 924.1K
- AMLX 1.7M
- Earning Date
- LDI 11-05-2024
- AMLX 11-07-2024
- Dividend Yield
- LDI N/A
- AMLX N/A
- EPS Growth
- LDI N/A
- AMLX N/A
- EPS
- LDI N/A
- AMLX N/A
- Revenue
- LDI $1,013,388,000.00
- AMLX $196,485,000.00
- Revenue This Year
- LDI N/A
- AMLX N/A
- Revenue Next Year
- LDI $23.17
- AMLX $149.49
- P/E Ratio
- LDI N/A
- AMLX N/A
- Revenue Growth
- LDI 10.36
- AMLX N/A
- 52 Week Low
- LDI $1.52
- AMLX $1.58
- 52 Week High
- LDI $3.71
- AMLX $19.95
- Technical
- Relative Strength Index (RSI)
- LDI 47.85
- AMLX 50.53
- Support Level
- LDI $2.22
- AMLX $5.09
- Resistance Level
- LDI $2.90
- AMLX $5.88
- Average True Range (ATR)
- LDI 0.16
- AMLX 0.61
- MACD
- LDI -0.02
- AMLX -0.20
- Stochastic Oscillator
- LDI 34.68
- AMLX 22.96
About LDI loanDepot Inc.
loanDepot Inc provides nonbank consumer lending solutions for individuals in the United States. It offers personal, residential home, home refinancing, mortgage and home equity loans. It also provides online mortgage loans for refinancing and home purchases. It serves customers through distribution channels, including consumer direct centres, retail branches, wholesale centres, and consumer finance and servicing centres in the United States. It competes with commercial banks and financial institutions.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.